Discussions among Us

Dear IMARS member,
welcome in this “discussion among us” space.
Here we would like to discuss in a very open and friendly way the hot topic research point related to Maillard Reaction.
Members of the Web Committee will launch some arguments in the next week and everybody can reply, make questions, comments, remarks.
For any advice or to propose new topics please contact the IMARS office.
I hope that all of you will contribute to animate this space. I know that it is not easy for many of us to discuss of specific scientific arguments inside our Institution and this web space can be a good opportunity to do this… please don’t be lazy!
Vincenzo.

To participate to the discussion, you need to be a Registered IMARS Member:

imars-logo-20091-150x68If you are not an IMARS Member:

please go to the Subscription Page in order to become partner of the community of researchers, academics, students, company operators

imars-logo-20091-150x68If you don’t have userid/password:

please go to the Registration Page

 

To read and partecipate it’s easy!

  • Go to the page containg the discussion you wish participate in
  • Make a question, write your opinion sending an email
  • No forum technicalities, only a simple email!
  • That’s it!

 



Active Discussions:

  1. Discussion #1: AGE, RAGE, Diseases, Inhibitions ….
    • Proposed on the 2oth, October, 2010 by Yasuhiko Yamamoto
      MD, PhD, Department of Biochemistry & Molecular Vascular Biology,
      Kanazawa University Graduate School of Medical Science
      Japan
    • Contribute on the 21st, October, 2010 by Alejandro Gugliucci
      MD, PhD, Professor and Associate Dean for Research
      Touro University-California
      USA
    • Contribute on the 22st, October, 2010 by Vincent Monnier
      Prof. Pathology/Biochem
      Case Western Reserve University, Department of Pathology
      Cleveland Ohio
      USA

* * * * * * * * * * * * * * * * * *

IF YOU WISH TO PARTICIPATE IN THE DISCUSSION OR TO MAKE A QUESTION, SIMPLY ENTER IN THE DISCUSSION PAGE AND SEND AN EMAIL TO [email protected]

* * * * * * * * * * * * * * * * * *

Comment are closed.